drugset / Trial / NCT00700687

Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib

NCT00700687

Phase 1 Completed 90 enrolled POZEN
RandomizedSingle-groupOpen-labelBasic science

Summary

We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments

Timeline

Start
2008-06
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule Oral
Subject Celecoxib Other / unclassified Oral
Subject PA32540 Unknown Oral

Indications

No indication recorded.